- Adverse event management in mass drug administration for neglected tropical diseasesArthur Caplan
NYU, Langone Medical Center, New York, New York Electronic address
Clin Ther 36:421-4. 2014..Denying beneficial research interventions and MDA programs intended to benefit millions requires sound ethical justification based on more than the identification of and rote response to AEs and SAEs. ..
- Enhancing patient autonomy through peer review to replace the FDA's rigorous approval processArthur Caplan
Division of Bioethics, New York University Langone Medical Center, New York, NY, USA
Health Aff (Millwood) 31:2236-40. 2012..The hypothetical comparative effectiveness case study in this month's Health Affairs does not appear to rise to the level that would be helpful to providers or patients...
- Without an adequate ethical infrastructure, the road to personalized medicine will be rocky at bestA L Caplan
Division of Medical Ethics, Langone Medical Center, New York University, New York, New York, USA
Clin Pharmacol Ther 92:411-2. 2012..There also remain significant ethical and policy obstacles that may hinder the arrival of personalized medicine. The emergence of new prenatal genetic tests make the resolution of these ethical challenges imperative...